Advertisement
Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Coons, J. C.
Right arrow Articles by Kusick, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coons, J. C.
Right arrow Articles by Kusick, K.
American Journal of Health-System Pharmacy, Vol. 66, Issue 6, 562-566
Copyright © 2009. American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/04/0602-1242$06.00


Clinical Consultation

Takotsubo cardiomyopathy

James C. Coons, Megan Barnes and Karissa Kusick

JAMES C. COONS, PHARM.D., BCPs, is Clinical Specialist, Cardiology; and MEGAN BARNES, PHARM.D., is Postgraduate Year One Resident, Allegheny General Hospital, Pittsburgh, PA; at the time of writing, she was Pharm.D. Student, Allegheny General Hospital. KARISSA KUSICK, PHARM.D., is Postgraduate Year One Resident, Cleveland Clinic, Cleveland, OH; at the time of writing, she was Pharm.D. Student, Allegheny General Hospital.

Address correspondence to Dr. Coons, Allegheny General Hospital, 320 East North Avenue, Pittsburgh, PA 15212 (jcoons{at}wpahs.org).


Purpose. Takotsubo cardiomyopathy is discussed as an alternative diagnosis to acute coronary syndrome (ACS) for emotionally and physically stressed patients with transientapical akinesis or dyskinesis of the left ventricle (LV) in the absence of coronary artery disease (CAD).

Summary. The name takotsubo cardiomyopathy refers to the hallmark shape of the LV during initial presentation. The apical portion of the heart balloons out, while the base of the heart has preserved systolic function. It is estimated that 0.5–2% of all patients with ACS symptoms may have takotsubo cardiomyopathy. Symptoms mimic those of a myocardial infarction (MI), and the evaluation of cardiac biomarkers, including troponin, may show a mild increase. Clinical symptoms are generally similar to ACS symptoms. While chest pain and dyspnea are most common, other features, such as cardiogenic shock, are rarer. A case example is described in which a 52-year-old white woman presented herself with complaints of chest pain and shortness of breath. She explained that the chest pain started after an argument with her supervisor. An electrocardiogram showed ST-segment elevation, and the patient was treated for ST-segment elevation MI. A left ventriculogram showed severe apical hypokinesis as well as anterolateral akinesis with a normal anterobasal segment, which led to the diagnosis of takotsubo cardiomyopathy. For patients with complications such as congestive heart failure, standard supportive care for takotsubo cardiomyopathy may include diuretics and vasodilators. In general, vasopressors and inotropes should be avoided because of the association of this syndrome with massive catecholamine release.

Conclusion. Takotsubo cardiomyopathy may be an alternative diagnosis to ACS for emotionally and physically stressed patients with transient-apical akinesis or dyskinesis of the LV in the absence of CAD. Because the exact pathophysiology has not been fully elucidated, the optimal management continues to evolve.

Index terms: Cardiomyopathy; Diagnosis; Diuretics; Vasodilating agents

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Society of Health-System Pharmacists.
Advertisement